ZOLEDRONAT Accord onco conc perf 4 mg/5ml flac

7680670710015 CH-67071 M05BA08 07.99.0.
ZOLEDRONAT Accord onco conc perf 4 mg/5ml flac
ZOLEDRONAT Accord onco conc perf 4 mg/5ml flac
ZOLEDRONAT Accord onco conc perf 4 mg/5ml flac
1 / 3
google

Details

Product number
6707101
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
acidum zoledronicum 4 mg ut acidum zoledronicum monohydricum, mannitolum, natrii citras anhydricus, aqua ad iniectabile q.s. ad solutionem pro 5 ml corresp. natrium 6.41 mg.

Articles (1)

Zoledronat Accord onco 4 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
13/12/2024
Professional SmPC
Français
13/12/2024
Professional SmPC
Italien
13/12/2024

Detailed composition

Substance Quantity Type Category
(N/A)
4.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
6.41 MG Substance HBESI

Reimbursement information

Public price
CHF 131.55
Specialties list
Yes
Generic
Yes
SL addition date: 01/12/2019

Authorization holder

Accord Healthcare AG

4103 Bottmingen

Authorization information

Swissmedic authorization number
67071
Drug name
Zoledronat Accord onco 4 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOPA
ATC Code
M05BA08
Authorization status
Z
Dispensation category
B
First authorization
23/05/2019
Authorization expiration date
31/12/9999
IT number
07.99.0.
Domain
Human medicine
Field of application
Knochenmetastasen solider Tumore und multiples Myelom, maligne Hyperkalzämie

Packaging details

Description (FR)
ZOLEDRONAT Accord onco conc perf 4 mg/5ml flac
Description (DE)
ZOLEDRONAT Accord onco Inf Konz 4 mg/5ml Durchstf
Market launch
23/05/2019
Narcotic (BTM)
No

Original drug

Aclasta, Infusionslösung
CHF 254.45
View original